CoChat
Sign Up
Cited by 138Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesGlobal Public Health Policies and Epidemiology

The DOI matches its Crossref record.

National Institutes of Health State-of-the-Science Conference Statement: Tobacco Use: Prevention, Cessation, and Control

NIH State-of-the-Science Panel*·2006·Annals of Internal Medicine
DOI 10.7326/0003-4819-145-11-200612050-00141
Open this paper in CoChat — free account

Abstract

NIH Conferences5 December 2006National Institutes of Health State-of-the-Science Conference Statement: Tobacco Use: Prevention, Cessation, and ControlFREENIH State-of-the-Science Panel*NIH State-of-the-Science Panel*Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-145-11-200612050-00141 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail National Institutes of Health (NIH) consensus and state-of-the-science statements are prepared by independent panels of health professionals and public representatives on the basis of 1) the results of a systematic literature review prepared under contract with the Agency for Healthcare Research and Quality (AHRQ), 2) presentations by investigators working in areas relevant to the conference questions during a 2-day public session, 3) questions and statements from conference attendees during open discussion periods that are part of the public session, and 4) closed deliberations by the panel during the remainder of the second day and the morning of the third. This statement is an independent report of the panel and is not a policy statement of the NIH or the federal government.The statement reflects the panel's assessment of medical knowledge available at the time the statement was written. Thus, it provides a "snapshot in time" of the state of knowledge on the conference topic. When reading the statement, keep in mind that new knowledge is inevitably accumulating through medical research.Tobacco use is the leading preventable cause of premature death in the United States. Each year, more than 440 000 Americans die of tobacco-related disease, accounting for 1 in every 5 deaths. Cigarette smoking is responsible for more than 30% of cancer deaths annually in the United States. Smoking also contributes substantially to deaths from heart disease, stroke, and chronic obstructive pulmonary disease. According to current estimates, 21% of American adults (44.5 million individuals) and 22% of American high school students (3.75 million individuals) smoke. Cigarettes are the predominant form of tobacco that Americans consume, but tobacco consumption also includes smokeless tobacco, cigars, and pipes. In addition to the toll in human lives, tobacco use is an enormous economic burden on society. From 1995 to 1999, estimated annual smoking-attributable economic costs in the United States were $75.5 billion for direct medical care for adults and $81.9 billion for lost productivity.Tobacco use per capita has decreased from about 14 pounds per year in the 1950s to about 5 pounds per year in 2000, suggesting that public health interventions have been effective. Yet it is unlikely that the United States will reach the Healthy People 2010 objectives of reducing smoking prevalence to 12% or less in adults and 16% or less in youth. Further progress in reducing tobacco use is an important challenge facing the public health, medical, and political communities.For these reasons, the National Cancer Institute and the NIH's Office of Medical Applications of Research sponsored a State-of-the-Science Conference on Tobacco Use: Prevention, Cessation, and Control on 12-14 June 2006 in Bethesda, Maryland. The key questions to be addressed at the State-of-the-Science Conference were: 1) What are the effective population- and community-based interventions to prevent tobacco use in adolescents and young adults, including among diverse populations? 2) What are the effective strategies for increasing consumer demand for and use of proven, individually oriented cessation treatments, including among diverse populations? 3) What are the effective strategies for increasing the implementation of proven, population-level, tobacco-use cessation strategies, particularly by health care systems and communities? 4) What is the effect of smokeless tobacco product marketing and use on overall harm to the population from tobacco use? 5) What is the effectiveness of prevention and of cessation interventions in populations with co-occurring morbidities and risk behaviors? 6) What research is needed to make the most progress and greatest public health gains nationally and internationally?At the conference, invited experts presented information pertinent to these questions, and a systematic literature review prepared under contract with AHRQ was summarized. The evidence report (www.ahrq.gov/clinic/epcix.htm) emphasized randomized, controlled trials; systematic reviews; and other experimental or observational studies with more than 100 participants. During the conference, attendees provided both oral and written statements in response to the key questions. The panel members weighed this evidence as they addressed the key conference questions.1. What Are the Effective Population- and Community-Based Interventions to Prevent Tobacco Use in Adolescents and Young Adults, Including among Diverse populations?Never startin

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-145-11-200612050-00141

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Panel*, N. S.-O.-T.-S.
Venue
Annals of Internal Medicine
Publisher
American College of Physicians
Published
2006-12-05
Volume
145
Issue
11
Pages
839-844
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
DOI
10.7326/0003-4819-145-11-200612050-00141
OpenAlex
W143532405
Cited by
138
References
0
Citations by year
2025: 1 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 4 · 2016: 2 · 2015: 6 · 2014: 3 · 2013: 11 · 2012: 10
FWCI
12.18
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
Keywords
tobacco use, tobacco control, smoking prevention, smoking cessation, cigarette smoking, smoking-related diseases, economic burden of smoking, smokeless tobacco, tobacco taxation, tobacco marketing regulation, tobacco advertising restrictions, adolescent smoking, smoking cessation interventions, tobacco control enforcement
MeSH terms
Smoking Prevention, Adolescent, Adult, Health Plan Implementation, Health Services Research, Humans, Preventive Health Services, Risk-Taking, Smoking, Tobacco, Smokeless, United States, Health Behavior, Comorbidity, Smoking Cessation, Marketing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review